Skip to content

Comparing the Pain Experience Between Patients Who Have and Who Have Not Undergone Dermatologic Procedures

A Pilot Study of 20 Subjects: Pain Experience in Naive vs. Non-naive Subjects Undergoing Energy-based Dermatologic Procedures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01285947
Enrollment
20
Registered
2011-01-28
Start date
2011-02-28
Completion date
2011-05-31
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

pain experience, energy devices, Ulthera, Thermage, VBeam

Brief summary

The purpose of this study is to compare the pain experience of patients who have not had dermatologic procedures (previously unexposed) using energy devices (lasers, radiofrequency, ultrasound, etc.) with patients who have previously had procedures (previously exposed) using energy devices. Based on previous clinical encounters, individuals with no prior experience with cosmetic procedures appear to experience more pain. However, no study to date has thoroughly examined this observation. As a result, this study has been designed to find a possible difference in pain perception between previously exposed and unexposed patients undergoing cosmetic procedures using energy devices.

Detailed description

Twenty subjects will be enrolled in the study: 10 subjects who have had cosmetic procedures in the past and 10 subjects who have not had such procedures. For each subject, pain tolerance in three areas will be assessed: temple, midface/cheek, and abdomen. In two areas of the face (temple and midface/cheek), a small sterile needle will be inserted into the skin along with three applications of the following devices that are FDA approved for use on the face: an ultrasound device (Ulthera), a pulsed dye laser (VBeam), and a radiofrequency (Thermage) device. Additionally, the abdomen will receive three of these four devices in a randomized order: small sterile needle insertion, a pulsed dye laser (VBeam) pulse, and a radiofrequency (Thermage) exposure (the ultrasound device, Ulthera, will not be used on the abdomen because it is currently not FDA approved for this indication). Subjects will then be asked to rate their pain after each application at each individual site using a pain scale. In addition, subjects will complete a questionnaire regarding their pain experiences and other possibly related factors before and after the procedures.

Interventions

DEVICEThermage

Radiofrequency Device - specific setting will be determined by the location and thickness of skin. Periorbital: 58-140 J/cm2 Midface: 81-124 J/cm2 Abdomen: 95-181 J/cm

OTHERNeedle Application

30-gauge needle insertion into skin

DEVICEVBeam Laser

Pulsed Dye Laser at the following settings: 7.5 J, 0.6ms, 10mm, DCD 30/20

DEVICEUlthera

Ultrasound Device at the following settings: Transducer Frequency Depth Image Depth DS 7-3.0 7 MHz 3.0mm 0-8mm DS 4-4.5 4 MHz 4.5mm 0-8mm DS 7-4.5 7 MHz 4.5mm 0-8mm

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Subjects of both genders, 18 to 65 years of age. 2. Subjects who are in good health. 3. Non-naïve (patients who have not had cosmetic procedures using energy devices): Subjects who have had three or more non-ablative laser procedures or any skin tightening procedure using an energy device. 4. Subjects who understand and are willing to provide informed consent for participation in the study and are able to communicate with the investigator.

Exclusion criteria

1. Subjects who have an active skin disease or skin infection in or around the treatment. 2. Subjects who are unable to understand the protocol or give informed consent. 3. Subjects with photophobia or who are unable to tolerate the treatments.

Design outcomes

Primary

MeasureTime frameDescription
Pain Rated by Subjects3 hours for all treatments in one visitThe mean pain scores will be compared between naïve subjects and non-naïve subjects averaged over the anatomical sites: periocular (temple), midface/cheek, and abdomen and over all the different treatments. Pain scores were recorded along a Visual Analog Scale (VAS) with 0 (no pain- better) to 10 (maximal pain-worst). This is a 10 cm long line in which the subject was asked to draw a line on the scale with 0 (no pain- better) at one end to 10 (maximal pain-worst) at the other end. The drawn line was measured on the 10 cm line using a ruler to obtain the score.

Countries

United States

Participant flow

Participants by arm

ArmCount
Naive Subjects
Subjects who have not previously undergone energy-based dermatologic procedures in the past.
10
Non-Naive Subjects
Subjects who have previously undergone energy-based dermatologic procedures in the past.
10
Total20

Baseline characteristics

CharacteristicNaive SubjectsNon-Naive SubjectsTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
10 Participants10 Participants20 Participants
Region of Enrollment
United States
10 participants10 participants20 participants
Sex: Female, Male
Female
10 Participants10 Participants20 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

Pain Rated by Subjects

The mean pain scores will be compared between naïve subjects and non-naïve subjects averaged over the anatomical sites: periocular (temple), midface/cheek, and abdomen and over all the different treatments. Pain scores were recorded along a Visual Analog Scale (VAS) with 0 (no pain- better) to 10 (maximal pain-worst). This is a 10 cm long line in which the subject was asked to draw a line on the scale with 0 (no pain- better) at one end to 10 (maximal pain-worst) at the other end. The drawn line was measured on the 10 cm line using a ruler to obtain the score.

Time frame: 3 hours for all treatments in one visit

ArmMeasureValue (MEAN)Dispersion
Naive SubjectsPain Rated by Subjects2.3 Units on a scaleStandard Deviation 1
Non-Naive SubjectsPain Rated by Subjects2.2 Units on a scaleStandard Deviation 1.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026